Healthcare Services

Increasing Adoption Of Parkinson’s Disease-Associated Gastrointestinal Issues Boost Intestinal Pseudo-Obstruction Treatment Market Is Influencing The Intestinal Pseudo-Obstruction Treatment Market

May 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Forecasted Market Size Of The Intestinal Pseudo-Obstruction Treatment Market Compare Between 2026 And 2030?

The intestinal pseudo-obstruction treatment market has shown significant growth in recent years. This market is predicted to expand from $24.74 billion in 2025 to $26.01 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 5.1%. The historical increase in this market can be linked to a restricted comprehension of gastrointestinal motility disorders, an uptick in hospitalizations for unidentifiable bowel obstruction symptoms, a reliance on drug-based symptomatic therapies, progress in diagnostic imaging and motility evaluations, and the proliferation of specialized gastroenterology clinics.

The intestinal pseudo-obstruction treatment market is projected to experience robust expansion over the coming years, with its valuation anticipated to reach $33.02 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.1%. This projected increase can be ascribed to several factors, including heightened investigation into intestinal motility disorders, an escalating need for individualized IPO treatment approaches, the increasing implementation of sophisticated diagnostic methods, the broadening scope of multidisciplinary gastroenterology services, and enhanced clinical directives for uncommon GI conditions. Significant patterns foreseen during this period encompass a heightened emphasis on timely and precise IPO diagnosis, the expanding utilization of diverse symptom management tactics, an increase in the adoption of conservative and non-invasive therapeutic options, the broadening of extensive disease management and supportive interventions, and a greater understanding of rare gastrointestinal motility disorders.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12995&type=smp

What Primary Factors Are Fueling The Expansion Of The Intestinal Pseudo-Obstruction Treatment Market?

The increasing incidence of Parkinson’s disease is anticipated to fuel the expansion of the Intestinal Pseudo-Obstruction Treatment Market. This neurodegenerative condition, which primarily affects dopamine-producing neurons in the brain’s substantia nigra, elevates the risk of Intestinal Pseudo-Obstruction (IPO) in affected individuals. This occurs because Parkinson’s disease impacts the enteric nervous system, resulting in gastrointestinal dysmotility that can lead to complications such as megacolon or intestinal blockage, including acute colonic pseudo-obstruction. For example, Sutter Health, a US-based nonprofit healthcare network, indicated in July 2025 that an estimated 1.1 million people in the United States were living with Parkinson’s disease in 2025, with projections showing this number increasing to 1.2 million by 2030. Thus, the rising prevalence of Parkinson’s disease is a key driver for the growth of the Intestinal Pseudo-Obstruction Treatment Market.

What Key Segment Areas Are Included In The Intestinal Pseudo-Obstruction Treatment Market Assessment?

The intestinal pseudo-obstruction treatment market covered in this report is segmented –

1) By Drug Class: Antibiotics, Antidepressants, Antidiarrheals

2) By Treatment: Medication, Surgery, Diet, Decompression, Other Treatments

3) By Route Of Administration: Oral, Intravenous, Other Routes Of Administration

4) By Diagnosis: Physical Examination, Biopsy, Blood Test, Gastric Emptying Tests, Imaging Tests, Other Diagnosis

5) By End User: Clinic, Hospitals, Other End Users

Subsegments:

1) By Antibiotics: Broad-Spectrum Antibiotics, Narrow-Spectrum Antibiotics

2) By Antidepressants: Tricyclic Antidepressants (TCAs), Selective Serotonin Reuptake Inhibitors (SSRIs)

3) By Antidiarrheals: Loperamide, Bismuth Subsalicylate

Who Are The Leading Firms Participating In The Intestinal Pseudo-Obstruction Treatment Market?

Major companies operating in the intestinal pseudo-obstruction treatment market are F. Hoffmann-La Roche AG, Merck Sharp & Dohme Corp, Bayer AG, Sanofi S.A., AstraZeneca plc, GSK plc, Takeda Pharmaceutical Company Limited, Amgen PLC, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Mylan N.V., Biogen Inc., Penn Medicine, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Allergan plc, Torrent Pharmaceuticals Limited, Basilea Pharmaceutica Ltd, Paratek Pharmaceuticals Inc., Melinta Therapeutics LLC, Tetraphase Pharmaceuticals Inc., Callisto Pharmaceuticals Inc.

Access The Complete Intestinal Pseudo-Obstruction Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/intestinal-pseudo-obstruction-treatment-global-market-report

Which Region Is The Primary Market For The Intestinal Pseudo-Obstruction Treatment Market?

North America was the largest region in the intestinal pseudo-obstruction treatment market in 2025. The regions covered in the intestinal pseudo-obstruction treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Intestinal Pseudo-Obstruction Treatment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=12995&type=smp

Browse Through More Reports Similar to the Global Intestinal Pseudo-Obstruction Treatment Market 2026, By The Business Research Company

Residential Building Construction Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/residential-building-construction-global-market-report

Construction Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/construction-global-market-report

Transportation Infrastructure Construction Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/transportation-infrastructure-construction-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795